News

 

Abbreviated interim report January – March 2021

 Strategic innovation generates new agreements Key figures in TSEK unless otherwise indicated  Jan-Mar 2021 Jan-Mar 2020 Jan-Dec 2020 Net…

Iconovo presents new inhaler ICOpre at RDD

Biostock published April 28th an article about Iconovo that can be found in its entirety below Iconovo has invested heavily in developing a new pre-metered…

Iconovo´s new inhaler ICOpre® to be presented at RDD 2021 workshop

ICOpre® Briefing Document (April 2021 update)

First approved patent in the US for Iconovo’s ICOone

Biostock published April 23th an article about Iconovo that can be found in its entirety below ICOone is Iconovo’s single-dose inhaler for simple…

First granted ICOone® patent in the United States

United States Patent and Trademark Office has announced the intention to grant a patent (Notice of Allowance) regarding Iconovo’s inhalation device…

Iconovos inhalator ska användas för svenskt covidvaccin (only in Swedish)

Ett svenskutvecklat covidvaccin som ges med en svensk inhalator till behövande i stora delar av världen. Det är målet när ISR köper rättigheterna…

Iconovo and ISR develop new covid-19 inhalation vaccine

Biostock published April 1th an article about Iconovo that can be found in its entirety below Yesterday, Inhalation device company Iconovo, which offers…

Iconovo signs agreement with ISR for the development of inhaled covid-19 vaccine

Iconovo AB (publ), a company developing complete inhalation products for a global market, today announced that it has signed an agreement with…

Granted ICOone patent in India provides innovative opportunities for Iconovo

Biostock published March 16th an article about Iconovo that can be found in its entirety below Last week, Iconovo announced that they have been granted…